By Amina Niasse NEW YORK, April 9 (Reuters) - Amazon.com said on Thursday its pharmacy unit will stock Eli Lilly's new weight ...

Eli Lilly has rolled out Foundayo, its oral GLP-1 pill, directly to consumers through its LillyDirect cash-pay channel, as ...

Eli Lilly and Company (NYSE:LLY) said that its new oral medication Foundayo (orforglipron) is now available in the United ...

Zepbound cuts and slower growth weigh now, but orforglipron FDA nod and CNTA deal fuel upside. Read the latest analysis on ...

Eli Lilly and Company (NYSE:LLY | LLY Price Prediction) and Novo Nordisk A/S (NYSE:NVO) reported quarterly results in early ...

The daily pill, called Foundayo, could make it easier for more people to lose weight.

By Leah Douglas and Christy Santhosh April 1 (Reuters) - The U.S. FDA on Wednesday approved Eli Lilly's weight-loss pill, ...

After winning the battle for injectable obesity medicines, Lilly hopes Foundayo can help it catch up in the oral market, ...

Eli Lilly & Co. agreed to buy sleep drug maker Centessa Pharmaceuticals Plc in a deal worth up to $7.8 billion, a sign the ...

Eli Lilly plans to acquire Centessa Pharmaceuticals, which has been conducting a midstage clinical trial of its lead drug.

Eli Lilly ( LLY 0.47%) has not performed well this year, with its shares down 13% to date. However, the company's stock ...